Health ❯ Pharmaceuticals

Drug Pricing

Market Dynamics Weight Loss Drugs Market Competition Medicare Access to Medicines Ozempic and Wegovy Novo Nordisk Government Policy Tariffs Healthcare Policy

Mexican Courts Keep Generics Off Market for Ozempic, Prolia/Xgeva and Lumigan

Tribunal rulings upholding data-protection claims now block manufacture or registration of generics, threatening patient access.

Pakistan Panel Approves Prices for 52 Life‑Saving Medicines

U.S. Creator Praises Free Five‑Minute Home Blood Test in Mumbai

Trump Promotes Mystery 'Freedom Fuel' Network Selling Below‑Market Gas

NPPA Fixes Ceiling Retail Prices for 39 Drug Formulations

U.S. Opens Section 301 Probe Into Germany's Drug Pricing

Senate Bill Would Require Drugmakers to Share FDA Filings and Bar Patent Enforcement

UK Pharmacies Lift Prices Up to 30% as Iran War Disrupts Drug Supplies

India’s Generic Semaglutide Wave Eats Into Mounjaro’s Lead as Novo Holds Share

Brazil Sets 2026 Medicine Price Caps With Three-Tier Increases Up to 3.81%

Trump Unveils TrumpRx Drug-Discount Portal as State Department Plans MAGA-Aligned Funding in Europe

US‑UK Deal Shields British Pharma From Tariffs for Three Years

U.S. and U.K. Strike Preliminary Deal Trading Tariff Relief for Higher NHS Drug Prices

WHO Endorses GLP‑1s for Obesity as Australia Adds Class‑Wide Mental Health Warning

Novo Nordisk Lowers Wegovy and Ozempic Cash Price to $349 and Unveils $199 Starter Offer

Germany Launches Pharma and MedTech Strategy Talks to Tackle Drug Shortages

White House Strikes Deals With Lilly and Novo to Cut GLP-1 Prices, Widen Medicare Access

Shutdown Reaches Day 36 as FAA Orders Flight Cuts and Markets Whipsaw

U.S. Envoy Warns of Pharma Pullout as AstraZeneca Rejects UK Drug-Price Offer

Kennedy Says Evidence Is Not Sufficient to Link Tylenol to Autism